Article info

Download PDFPDF

Review: infliximab increases response and remission rates in fistulising or treatment-resistant Crohn’s disease
Free

Citation

Review: infliximab increases response and remission rates in fistulising or treatment-resistant Crohn’s disease

Publication history

  • First published November 1, 2002.
Online issue publication 
November 01, 2002

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.